Forsidebilde av showet Ozempic vs Wegovy — What's the Difference?

Ozempic vs Wegovy — What's the Difference?

Podkast av Inception Point AI

engelsk

Helse og personlig utvikling

Tidsbegrenset tilbud

2 Måneder for 19 kr

Deretter 99 kr / MånedAvslutt når som helst.

  • 20 timer lydbøker i måneden
  • Eksklusive podkaster
  • Gratis podkaster
Kom i gang

Les mer Ozempic vs Wegovy — What's the Difference?

Discover why semaglutide exists as two FDA-approved drugs with different purposes and doses. Julia Cartwright unravels the regulatory decisions and dosing science that distinguish Ozempic for diabetes from Wegovy for weight management. Learn what doctors consider when choosing between them and why insurance might make the decision for you. For more content like this, visit QuietPlease.ai This content was created in partnership and with the help of Artificial Intelligence AI.

Alle episoder

4 Episoder

episode Ozempic vs Wegovy — What's the Difference? - What Your Doctor Is Really Thinking cover

Ozempic vs Wegovy — What's the Difference? - What Your Doctor Is Really Thinking

Julia Cartwright examines what doctors really consider when prescribing Ozempic versus Wegovy—the same semaglutide molecule with different FDA approvals, dosing, and insurance coverage. From BMI thresholds and prior authorizations to off-label use and cost barriers, this episode unpacks the complex medical and bureaucratic factors shaping your prescription in ways you never realized. Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTV This content was created in partnership and with the help of Artificial Intelligence AI.

7. april 2026 - 25 min
episode Ozempic vs Wegovy — What's the Difference? - One Molecule, Two Labels cover

Ozempic vs Wegovy — What's the Difference? - One Molecule, Two Labels

Join host Julia Cartwright as she unravels how one molecule—semaglutide—became two FDA-approved drugs with distinct missions. We explore the clinical trials, regulatory decisions, and dosing strategies that split Ozempic (for diabetes) from Wegovy (for weight management), revealing why this distinction matters for patients, coverage, and modern medicine's evolving approach to treating chronic disease. Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTV This content was created in partnership and with the help of Artificial Intelligence AI.

7. april 2026 - 26 min
Registrer deg for å lytte
Enkelt å finne frem nye favoritter og lett å navigere seg gjennom innholdet i appen
Enkelt å finne frem nye favoritter og lett å navigere seg gjennom innholdet i appen
Liker at det er både Podcaster (godt utvalg) og lydbøker i samme app, pluss at man kan holde Podcaster og lydbøker atskilt i biblioteket.
Bra app. Oversiktlig og ryddig. MYE bra innhold⭐️⭐️⭐️

Velg abonnementet ditt

Mest populær

Tidsbegrenset tilbud

Premium

20 timer lydbøker

  • Eksklusive podkaster

  • Ingen annonser i Podimo shows

  • Avslutt når som helst

2 Måneder for 19 kr
Deretter 99 kr / Måned

Kom i gang

Premium Plus

100 timer lydbøker

  • Eksklusive podkaster

  • Ingen annonser i Podimo shows

  • Avslutt når som helst

Prøv gratis i 14 dager
Deretter 169 kr / måned

Prøv gratis

Bare på Podimo

Populære lydbøker

Ofte stilte spørsmål

Flere spørsmål og svar
Kom i gang

2 Måneder for 19 kr. Deretter 99 kr / Måned. Avslutt når som helst.